Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001933414-25-000058
Filing Date
2025-05-12
Accepted
2025-05-12 17:31:11
Documents
56
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mlys-20250331.htm   iXBRL 10-Q 647164
2 EX-31.1 mlys2025q110qex311.htm EX-31.1 9813
3 EX-31.2 mlys2025q110qex312.htm EX-31.2 9750
4 EX-32.1 mlys2025q110qex321.htm EX-32.1 5050
5 EX-32.2 mlys2025q110qex322.htm EX-32.2 4954
  Complete submission text file 0001933414-25-000058.txt   3565374

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlys-20250331.xsd EX-101.SCH 27705
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlys-20250331_cal.xml EX-101.CAL 32212
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlys-20250331_def.xml EX-101.DEF 98027
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlys-20250331_lab.xml EX-101.LAB 382729
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlys-20250331_pre.xml EX-101.PRE 251976
59 EXTRACTED XBRL INSTANCE DOCUMENT mlys-20250331_htm.xml XML 325663
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41614 | Film No.: 25936228
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)